Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04282148 · ClinicalTrials.gov registry record · NA

Abbott Next Generation Drug Eluting Stent 48mm Study

A NA study of Coronary Artery Disease, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
107
Enrollment target
20
Study locations

NCT04282148 is a NA study of Coronary Artery Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 107 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (92% lower). The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04282148, a NA study of Coronary Artery Disease, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects with coronary artery disease (CAD) due to de novo native coronary artery long lesions.

Conditions Studied

Coronary Artery Disease

Interventions

  • DEVICE ABT NG DES 48 EECSS

Study Locations (20)

California

  • Scripps Memorial Hospital - La Jolla - La Jolla
  • UCLA Medical Center Santa Monica - Santa Monica

Florida

  • The Cardiac & Vascular Institute Research Foundation, LLC - Gainesville
  • Shands at the University of Florida - Gainesville

Kansas

  • Via Christi Regional Medical Center - St. Francis Campus - Wichita
  • Cardiovascular Research Institute of Kansas - Wichita

Ohio

  • The Lindner Center - Cincinnati
  • St. Vincent Mercy Medical Center - Toledo

Texas

  • Baylor Scott & White Heart & Vascular Hospital - Dallas
  • The Heart Hospital Baylor Plano - Plano

Arizona

  • HonorHealth - Scottsdale

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • Minneapolis Heart Institute - Minneapolis

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2020-06-17
Est. Completion 2023-09-17
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04282148

The ClinicalTrials.gov registry entry for NCT04282148 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (92% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which ABT NG DES 48 EECSS is the first listed.

NCT04282148 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Florida, Kansas.

Frequently Asked Questions

What is clinical trial NCT04282148 about?

NCT04282148 is a clinical study titled "Abbott Next Generation Drug Eluting Stent 48mm Study". The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects with coronary artery disease (CAD) due to de novo native coronary artery long lesions.

What is the current status of trial NCT04282148?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2020-06-17. Estimated completion is 2023-09-17.

What conditions does trial NCT04282148 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT04282148?

The interventions under investigation include: ABT NG DES 48 EECSS (DEVICE).

Who is sponsoring clinical trial NCT04282148?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04282148 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Kansas, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.